Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

It’s rare that people have a disorder where cortisol on its own is the cause. If a person’s cortisol level is chronically low, doctors would diagnose them with adrenal insufficiency. This includes an ...

Surgical and conservative management show similar impacts on CV risk and mortality in bilateral adrenal tumors and cortisol excess.

Despite a decline in net income, Corcept Therapeutics Inc (CORT) reports strong revenue growth and optimistic guidance for 2026, driven by increased demand and promising trial results.

Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.

Lupita Nyong'o got candid about her uterine fibroid diagnosis, explaining that while she felt "shame" over it, she was glad to be speaking up and advocating for women's health.

Eligibility covers domesticated dogs and cats of various breeds, typically from about three months to specified upper age ...

Robbins LLP is Investigating Allegations that Corcept Therapeutics Incorporated (CORT) Misled Investors Regarding the ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation common stock between October 31, 2024 ...

Investing.com -- Corcept Therapeutics Incorporated (NASDAQ:CORT) reported fourth quarter results that fell short of Wall Street expectations, with both earnings and revenue missing analyst estimates ...

Corcept Therapeutics is upgraded to Buy after a patent loss and FDA setback, with focus shifting to relacorilant in oncology. Click for more information on CORT.

Norman Parathyroid Center, Clayman Thyroid Center, and Carling Adrenal Center Expand Their Lead as the World’s ...